HCM in Two Acts 🎭: Aficamten, Mavacamten & Dueling Data in the Quest to Tame HCM
Dr RR Baliga's "Got Knowledge Doc" Podkast
September 20, 20257m 8s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🚨 New Podcast Drop! 🎙️
"Myosin, Metrics & Momentum 🧬📈🫀" dives into 3 landmark NEJM articles on Aficamten vs Mavacamten in hypertrophic cardiomyopathy.
We decode:
🔹 MAPLE-HCM (obstructive HCM)
🔹 ODYSSEY-HCM (nonobstructive HCM)
🔹 Expert editorial insights on PROs, EF, & trial design
🎯 Learn what matters: peak VO₂ vs PROs, safety signals, and the road ahead in precision cardiomyopathy care.
🎧 Tune in and share! #HCM #CardioTwitter #NEJM #HeartFailure #MyosinInhibitors #Podcast